Free Delivery Over $100
|
|
|||
|
||||
OverviewThis broad view of epigenetic approaches in drug discovery combines methods and strategies with individual targets, including new and largely unexplored ones such as sirtuins and methyl-lysine reader proteins. Presented in three parts - Introduction to Epigenetics, General Aspects and Methodologies, and Epigenetic Target Classes - it covers everything any drug researcher would need in order to know about targeting epigenetic mechanisms of disease. Epigenetic Drug Discovery is an important resource for medicinal chemists, pharmaceutical researchers, biochemists, molecular biologists, and molecular geneticists. Full Product DetailsAuthor: Wolfgang Sippl (University of Halle-Wittenberg, Germany) , Manfred Jung (Albert Ludwigs University, Freiburg, Germany) , Raimund Mannhold (University of Dusseldorf, Ge) , Helmut Buschmann (Aachen, Germany)Publisher: Wiley-VCH Verlag GmbH Imprint: Blackwell Verlag GmbH Dimensions: Width: 17.50cm , Height: 2.80cm , Length: 25.20cm Weight: 1.111kg ISBN: 9783527343140ISBN 10: 3527343148 Pages: 504 Publication Date: 30 January 2019 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock  The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor Information"Wolfgang Sippl, PhD, holds the chair in Medicinal Chemistry at the Institute of Pharmacy at the Martin Luther University Halle-Wittenberg. Manfred Jung, PhD, is a full professor for Pharmaceutical Chemistry at the University of Freiburg and the co-chairman of the SFB research project ""Medical Epigenetics""." Tab Content 6Author Website:Countries AvailableAll regions |
||||
